Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimal surgery for papillary thyroid carcinoma

R Udelsman1, E Lakatos, P Ladenson

  • 1Division of Endocrine and Oncologic Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.

World Journal of Surgery
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parathyroid, Thyroid and Recurrent Laryngeal Nerve Anatomy in an Indian Rhinoceros (Rhinoceros unicornis).

World journal of surgery·2017
Same author

Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

Human achaete-scute homolog-1 is highly expressed in a subset of neuroendocrine tumors.

Oncology reports·2011
Same author

Thyroid uptake of radioactive iodine and scintigraphy in mice.

Thyroid : official journal of the American Thyroid Association·2006
Same author

Quantitative assessment of promoter methylation profiles in thyroid neoplasms.

The Journal of clinical endocrinology and metabolism·2005
Same author

Parathyroid surgery in familial hyperparathyroid disorders.

Journal of internal medicine·2004
Same journal

Mapping Plastic Reconstructive Surgical Needs and Access Barriers in Sub-Saharan Africa: A Scoping Review.

World journal of surgery·2026
Same journal

Correction to "Guidelines for Essential Trauma Care: Second Edition (2026)".

World journal of surgery·2026
Same journal

Assessing the Burden of Operatively Managed Extremity Fractures in Malawi: A Tale of Two Tertiary Hospitals.

World journal of surgery·2026
Same journal

The Impact of Obesity on Intraoperative, Oncological, and Postoperative Endpoints in Robotic Pancreaticoduodenectomy.

World journal of surgery·2026
Same journal

Prediction Models for Sentinel Lymph Node Metastasis in Clinically Node-Negative Breast Cancer: Validation of Existing Nomograms, Model Development, and Ensemble Evaluation.

World journal of surgery·2026
Same journal

Indicators for Monitoring Recovery From Surgery to Discharge Using Accelerometer in Patients With Esophageal Cancer.

World journal of surgery·2026
See all related articles

Determining the best surgery for differentiated thyroid cancer requires careful planning. A cause-specific mortality trial is the most objective and statistically valid approach for papillary thyroid carcinoma research.

Area of Science:

  • Endocrinology
  • Surgical Oncology
  • Clinical Trial Design

Background:

  • The optimal surgical approach for differentiated thyroid carcinoma remains debated.
  • Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer.

Purpose of the Study:

  • To analyze the feasibility, scope, sample size, and follow-up duration for designing a randomized trial.
  • To determine the optimal operation for papillary thyroid carcinoma.

Main Methods:

  • Statistical analysis was employed to design a prospective randomized trial.
  • Comparison of endpoints including complications, recurrence, and cause-specific mortality.

Main Results:

  • A trial comparing complications is not feasible due to the large sample size required (approx. 12,000 patients).

Related Experiment Videos

  • A recurrence trial (360-800 patients, 6-10 year follow-up) is feasible but may have compromised detection and bias.
  • A cause-specific mortality trial requires a substantial sample size (n=3100) but offers the most objective and statistically valid endpoint.

    • Conclusions:

    • Cause-specific mortality is the most objective and statistically valid endpoint for trials on papillary thyroid carcinoma surgery.
    • Further research is needed to confirm the optimal surgical strategy for differentiated thyroid cancer.